Arcutis' ZORYVE cream gets strong AAD recommendation for pediatric atopic dermatitis

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. IBM
3. PRIM
4. MU
5. DPZ
6. NAVN
7. DFTX
8. META
9. IMNN
10. ACN

Go back to Arcutis' ZORYVE cream gets strong AAD recommendation for pediatric atopic dermatitis
(NASDAQ: ARQT) Delayed: 26.66 --0 (-0%)
Previous Close $26.66    52 Week High $ 
Open $26.66    52 Week Low $ 
Day High $26.66    P/E N/A 
Day Low $26.66    EPS $ 
Volume 1,703